isunakinra (EBI-005) - Sesen Bio
Eleven Biotherapeutics: Q4 2014 Results (Eleven Biotherapeutics) - Mar 8, 2015 - Anticipated BLA filing for moderate to severe dry eye disease by end of 2016 
Anticipated BLA • Immunology
http://seekingalpha.com/article/2972666-eleven-biotherapeutics-ebio-ceo-abbie-celniker-on-q4-2014-results-earnings-call-transcript?part=single
 
Mar 8, 2015
 
.